Combination drug market declines 56% in March as govt clamps down
With the government clamping down on combination drugs, the latest market data shows that in March the fixed dose combination (FDC) market declined by 56.4 per cent, when the non-FDC…
Govt considering ban on over 150 combination drugs: Report
NEW DELHI: The government could ban over 150 combination drugs after an expert panel found that those have no therapeutic justification, Mint reported. The Chandrakant Kokate-led expert panel, which was…
Health Ministry bans 80 more fixed-dose combination drugs
New Delhi: The Union Health Ministry has banned 80 more fixed-dose combination (FDC) drugs which include antibiotics, painkillers, medicines used for treating fungal and bacterial infections, hypertension and anxiety, officials…
343 FDCs should continue banned as they expose Patients To health risks
An expert panel team appointed by the government has recommended the continuation of the ban on 343 fixed-dose combination (FDC) drugs. The expert sub-committee of the Drugs Technical Advisory Board…
Wockhardt, two others under lens for selling drugs without approval
New Delhi: Major drug makers, including Wockhardt Ltd, are under the scanner of the pharma regulator for allegedly launching combination drugs to treat diabetes and fungal infection without mandatory prior…
Delhi HC quashes government ban on FDC drugs
New Delhi: In a major relief to the pharmaceutical sector, the Delhi high court on Thursday quashed a government-imposed ban on fixed dose combination (FDC) drugs. The cases—filed by several…
DRUG CONTROLLER OF UTRAKHAND DISCLOSES TRUTH
New Delhi May 17, 2016, Drug Controller of Utrakhand had issued warning notice dated May 06 2016 to all manufacturers to come personally with original approval copy issued up till…
FDC BAN DRAMA CONTINUES
New Delhi Medicare News, May 15, 2016: Honourable high court should call all regulators of all levels who gave approval to fixed dose combination without taking care whether it is…
Delhi HC questions government’s decision; drug ban saga continues
New Delhi :- Pfizer’s cough syrup Corex, which had received a ‘No Objection Certificate’ (NOC) from DCGI in 1995, was brought up as an example during the proceedings. The Delhi…
